Oncolytics Biotech Inc T.ONC

Pfizer partners with startup Flagship valued at US$7 Billion

[Noteable]

Julu 18, 2023 - "Pfizer and Flagship will explore up to 10 single-asset \start-up programs, which Pfizer will fund and have the option to acquire. Flagship and its companies will be eligible to receive up to $700 million in milestones and royalties for each program that hits the market, giving Tuesday’s deal a maximum potential value of $7 billion."

"The collaboration will leverage Flagship’s ecosystem of biotechnology platforms (bio-platforms) ....."

This partnership indicates that Pfizer, like other Big Pharma companies are facing a looming patent cliff and ar seeking ways to fill their product pipelines to off-set the loss of revenue from their former blockbuster products. As described earlier, M&A valuations for late-state clinical stage companies developing biologicals are at premium pricing, and have become very competitive assets to acquire, particularly in immuno-ocology products in the treatment of multiple cancers.

https://www.biospace.com/article/pfizer-inks-potential-7b-deal-with-flagship-to-deepen-pipeline/

[ONCY's late-stage phase 3 bio-platform in pelareorep addresses multiple unmet medical needs in the sought after oncology market space and is fairly valued for an M&A deal at between US$10 Billion to US$15 Billion.]

[Noteable]

Should read: July 18, 2023 - Pfizer and Flagship join forces on the hunt for new drugs. " The collaboration involves Flagship’s “Pioneering Medicines” (early stage development) initiative, which has struck similarly structured deals in the recent past ..."  "Flagship pitches (it's Pioneering Medicines Initiative)  as a way to tap into all the research those companies

[Noteable]

"While Moderna is included in the Flagship ecosystem, Biondi said the partnership will more likely include companies in earlier-stage development.... Flagship designed Pioneering Medicines to create new therapeutics by expanding the VC firm’s innovations platforms into previously unexplored areas." "The purpose of the potential programs will be to address unmet needs within

[fox7mf]

This is exactly the type of BD deal I hope Oncy avoids like the plague. Upfront monies followed by catalysts, milestones and unending shareholder frustration. They will most likely get something similar, unfortunately. 

[Noteable]

Partnerships are formed around early stage companies. ONCY is a late stage Phase 3-ready bio-platform company whose platform addresses multiple cancers with unmet treatment needs, like the kind of potential high-value assets that Big Pharma companies are seeking to acquire given their need to address their looming patent cliffs and replenishment of their product portfolios, that are specifically

[Noteable]

Should read: " ..that has the kind of potential high-value assets that Big Pharma companies are seeking ..."

[Lesalpes29]

Humm.. not sure that Parsons, Rigby and the rest of the board want that kind of deal. We will see.

[Noteable]

No one said they did. The purpose of this subject was to demonstrate that Big Pharma is prepared to  spend Billion$$ and is having to reach further upstream in the R&D process in an effort to gain new assets to help stave off the looming patent cliff that they face and replenish their dwindling product portfolios. I can't seek how some on this message board keep missing this

[fasttrack5]

would that kind of buyout be worth over $100 per ONC share?  :)

[JohnnyYeg]

I have a spreadsheet with the values:

[JohnnyYeg]

 Buyout Price ($CDN)   Buyout Price ($US)   $CDN/Sh:   $US/Sh:   $   19,753,500,000.00  $  15,000,000,000.00  $         280.19  $         212.77  $   18

[fox7mf]

I'm no longer that preoccupied with the "how much" as I know it should be a buyout & for two ph3  indications and possibly/probably a 3rd (CRC) the winning bid will have to be huge. I'm much more fixated with the "when". I don't want to even think about this stock by years end. Good luck peeps.

[JohnnyYeg]

Amen Foxy!

[13X2413]

There's nothing wrong with hoping for miracles. I'm still waiting for a lottery win too. 

[Angler101]

Wow, 13X2413!....Lol!......it's hard to believe that someone with such an obviously impressive intellect as yourself would fall for what my old man used to call the "stupidity tax" of lottery tickets!....but good luck with that!

[Lesalpes29]

Speculative play... really not at a lottery ticket level! Try to find something else!

[Noteable]

Big Pharma is prepared to spend Billion$$ and is having to reach further upstream in the R&D process in an effort to gain new assets to help stave off the looming patent cliff that they face and replenish their dwindling product portfolios. As described earlier, M&A valuations for late-state clinical stage companies developing biologicals continue to be acquired at premium pricing, and